Skip to main content

Table 1 Subject characteristics

From: Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia

Characteristic

n/N a (%)

Aged <18 years old

42/432 (10)

Aged ≥35 years old

33/432 (8)

Doses of SPb-IPTpc taken

0 doses

34/435 (8)

1 dose

115/435 (26)

2 doses

142/435 (33)

3 doses

135/435 (31)

4 doses

9/435 (2)

Primigravid women

159/433 (37)

Paucigravid women

218/432 (51)

Multigravid women

214/432 (50)

From rural communities

255/433 (59)

Married

365/433 (84)

Home is treated with indoor residual spraying

149/411 (35)

Owns an insecticide treated net (ITN)

217/435 (50)

Slept under ITN during the last night at home

180/435 (42)

Delivered during the wet season

345/434 (80)

Self-reported doses of SP-IPTp

33/435 (8)

  1. aTotal contributing responses.
  2. bSP = sulphadoxine pyrimethamine.
  3. cIPTp = intermittent preventive treatment for malaria in pregnancy.